Search

everythinglearnresearchcommunity

for

Search:↓

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Cinnamon can help manage symptoms of polycystic ovary syndrome, improve menstrual cycles and fertility, and positively affect cholesterol and blood sugar levels, but more research is needed to confirm these effects and find the best dosage.

Early hair greying may increase the risk of heart disease.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Gray hair can potentially be managed or reversed with treatments that boost melanin production and address nutritional deficiencies.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Long-term finasteride treatment reduces depression and brain issues in obese male rats.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Controlling inflammation can help heal diabetic foot ulcers.

PCOS should be reclassified into two types based on hormone levels and symptoms.

Fibroblasts are important in healing diabetic wounds, but high sugar levels can harm their function and slow down the healing process.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

Androgenetic alopecia is linked to factors like age, family hair loss history, diet, and health conditions.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.